Cambridge Instruments LLC is categorized under Pharmaceutical Machinery Manufacturers in Madison, CT and active since 2003.
Cambridge Instruments LLC was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Chuck Balas at the company’s single location by writing to 45 Beekman Place, Madison, Connecticut CT 06443 or by phoning (203) 245-2160. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cambridge Instruments LLC |
| Contact Person: | Chuck Balas |
| Address: | 45 Beekman Place, Madison, Connecticut 06443 |
| Phone Number: | (203) 245-2160 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Machinery Manufacturers |
| SIC Code: | 3559 |
| NAICS Code: | 333249 |
| Share This Business: |
Cambridge Instruments LLC was started in 2003 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chuck Balas for inquiries that concern Cambridge Instruments LLC by calling the company number (203) 245-2160, as your correspondence is most welcome. Additionally, the physical location of the single location of Cambridge Instruments LLC can be found at the coordinates as well as the street address 45 Beekman Place in Madison, Connecticut 06443.
For its online presence, you may visit Cambridge Instruments LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.